scholarly journals Naïve, unenculturated chimpanzees fail to make and use flaked stone tools

2021 ◽  
Vol 1 ◽  
pp. 20
Author(s):  
Elisa Bandini ◽  
Alba Motes-Rodrigo ◽  
William Archer ◽  
Tanya Minchin ◽  
Helene Axelsen ◽  
...  

Background: Despite substantial research on early hominin lithic technologies, the learning mechanisms underlying flake manufacture and use are contested. To draw phylogenetic inferences on the potential cognitive processes underlying the acquisition of both of these abilities in early hominins, we investigated if and how one of our closest living relatives, chimpanzees (Pan troglodytes), could learn to make and use flakes. Methods: Across several experimental conditions, we tested unenculturated, naïve chimpanzees from two independent populations (n=11) for their abilities to spontaneously make and use their own flakes as well as to use pre-made flakes made by a human experimenter. Results: Despite the fact that the chimpanzees demonstrated an understanding of the requirements of the task and that subjects were sufficiently motivated and had ample opportunities to develop these behaviours, none of the chimpanzees tested, made or used flakes in any of the experimental conditions. Conclusions: These results differ from all previous ape flaking experiments, which found flake manufacture and use in bonobos and one orangutan. However, these earlier studies tested human-enculturated apes and provided the test subjects with flake making and using demonstrations. The contrast between these earlier positive findings and our negative findings (despite using a much larger sample size) suggests that human enculturation and/or human demonstrations may be necessary for chimpanzees to acquire these abilities. The data obtained in this study are consistent with the hypothesis that flake manufacture and use might have evolved in the hominin lineage after the split between Homo and Pan 7 million years ago, a scenario further supported by the initial lack of flaked stone tools in the archaeological record after this split. We discuss possible evolutionary scenarios for flake manufacture and use in both non-hominin and hominin lineages.

2021 ◽  
Vol 1 ◽  
pp. 20
Author(s):  
Elisa Bandini ◽  
Alba Motes-Rodrigo ◽  
William Archer ◽  
Tanya Minchin ◽  
Helene Axelsen ◽  
...  

Background: Despite substantial research on early hominin lithic technologies, the learning mechanisms underlying flake manufacture and use are contested. To draw phylogenetic inferences on the potential cognitive processes underlying the acquisition of both of these abilities in early hominins, we investigated if and how one of our closest living relatives, chimpanzees (Pan troglodytes), could learn to make and use flakes. Methods: Across several experimental conditions, we tested eleven task-naïve chimpanzees (unenculturated n=8, unknown status n=3) from two independent populations for their abilities to spontaneously make and subsequently use flakes as well as to use flakes made by a human experimenter. Results: Despite the fact that the chimpanzees seemed to understand the requirements of the task, were sufficiently motivated and had ample opportunities to develop the target behaviours, none of the chimpanzees tested made or used flakes in any of the experimental conditions. Conclusions: These results differ from all previous ape flaking experiments, which found flake manufacture and use in bonobos and one orangutan. However, these earlier studies tested human-enculturated apes and provided test subjects with flake making and using demonstrations. The contrast between these earlier positive findings and our negative findings (despite using a much larger sample size) suggests that enculturation and/or demonstrations may be necessary for chimpanzees to acquire these abilities. The data obtained in this study are consistent with the hypothesis that flake manufacture and use might have evolved in the hominin lineage after the split between Homo and Pan 7 million years ago, a scenario further supported by the initial lack of flaked stone tools in the archaeological record after this split. We discuss possible evolutionary scenarios for flake manufacture and use in both non-hominin and hominin lineages.


1990 ◽  
Vol 29 (03) ◽  
pp. 243-246 ◽  
Author(s):  
M. A. A. Moussa

AbstractVarious approaches are considered for adjustment of clinical trial size for patient noncompliance. Such approaches either model the effect of noncompliance through comparison of two survival distributions or two simple proportions. Models that allow for variation of noncompliance and event rates between time intervals are also considered. The approach that models the noncompliance adjustment on the basis of survival functions is conservative and hence requires larger sample size. The model to be selected for noncompliance adjustment depends upon available estimates of noncompliance and event rate patterns.


2020 ◽  
Vol 26 (2) ◽  
pp. 218-227
Author(s):  
Yi-Hang Chiu ◽  
Chia-Yueh Hsu ◽  
Mong-Liang Lu ◽  
Chun-Hsin Chen

Background: Clozapine has been used in treatment-resistant patients with schizophrenia. However, only 40% of patients with treatment-resistant schizophrenia have response to clozapine. Many augmentation strategies have been proposed to treat those clozapine-resistant patients, but the results are inconclusive. In this review, we intended to review papers dealing with the augmentation strategies in the treatment of clozapineresistant patients with schizophrenia. Method: We reviewed randomized, double-blind, placebo- or sham-controlled trials (RCT) for clozapine-resistant patients with schizophrenia in Embase, PsycINFO, Cochrane, and PubMed database from January 1990 to June 2019. Results: Antipsychotics, antidepressants, mood stabilizers, brain stimulation, such as electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation, and other strategies, were used as an augmentation in clozapine-resistant patients with schizophrenia. Except for better evidence in memantine with 2 RCTs and cognitive behavior therapy in 2 studies to support its effectiveness, we found that all the other effective augmentations, including sulpiride, ziprasidone, duloxetine, mirtazapine, ECT, sodium benzoate, ginkgo biloba, and minocycline, had only one RCT with limited sample size. Conclusion: In this review, no definite effective augmentation strategy was found for clozapine-resistant patients. Some potential strategies with beneficial effects on psychopathology need further studies with a larger sample size to support their efficacy.


2021 ◽  
Vol 11 (3) ◽  
pp. 234
Author(s):  
Abigail R. Basson ◽  
Fabio Cominelli ◽  
Alexander Rodriguez-Palacios

Poor study reproducibility is a concern in translational research. As a solution, it is recommended to increase sample size (N), i.e., add more subjects to experiments. The goal of this study was to examine/visualize data multimodality (data with >1 data peak/mode) as cause of study irreproducibility. To emulate the repetition of studies and random sampling of study subjects, we first used various simulation methods of random number generation based on preclinical published disease outcome data from human gut microbiota-transplantation rodent studies (e.g., intestinal inflammation and univariate/continuous). We first used unimodal distributions (one-mode, Gaussian, and binomial) to generate random numbers. We showed that increasing N does not reproducibly identify statistical differences when group comparisons are repeatedly simulated. We then used multimodal distributions (>1-modes and Markov chain Monte Carlo methods of random sampling) to simulate similar multimodal datasets A and B (t-test-p = 0.95; N = 100,000), and confirmed that increasing N does not improve the ‘reproducibility of statistical results or direction of the effects’. Data visualization with violin plots of categorical random data simulations with five-integer categories/five-groups illustrated how multimodality leads to irreproducibility. Re-analysis of data from a human clinical trial that used maltodextrin as dietary placebo illustrated multimodal responses between human groups, and after placebo consumption. In conclusion, increasing N does not necessarily ensure reproducible statistical findings across repeated simulations due to randomness and multimodality. Herein, we clarify how to quantify, visualize and address disease data multimodality in research. Data visualization could facilitate study designs focused on disease subtypes/modes to help understand person–person differences and personalized medicine.


2014 ◽  
Vol 2014 ◽  
pp. 1-12 ◽  
Author(s):  
Rubayet Elahi ◽  
Ausraful Islam ◽  
Mohammad Sharif Hossain ◽  
Khaja Mohiuddin ◽  
Andrea Mikolon ◽  
...  

The parasites of generaHaemoproteus, Plasmodium,andLeucocytozoonare well-known avian haematozoa and can cause declined productivity and high mortality in wild birds. The objective of the study was to record the prevalence of haematozoan parasites in a wide range of wetland birds in Bangladesh. Six species ofHaemoproteus, seven species ofPlasmodium, one unidentified species ofLeucocytozoon, and one unidentified microfilaria of the genusParonchocercawere found. Data on the morphology, size, hosts, prevalence, and infection intensity of the parasites are provided. The overall prevalence among the birds was 29.5% (95 out of 322 birds). Of those, 13.2% (42 of 319) of birds were infected withHaemoproteusspp., 15.1% withPlasmodiumspp. (48 of 319) and 0.6% withLeucocytozoonspp. (2 of 319). Two birds were positive for bothHaemoproteussp. andPlasmodiumsp. A single resident bird,Ardeola grayii, was found positive for an unidentified microfilaria. Prevalence of infection varied significantly among different bird families. Wild birds of Bangladesh carry several types of haematozoan parasites. Further investigation with a larger sample size is necessary to estimate more accurately the prevalence of haematozoan parasites among wild birds as well as domestic ducks for better understanding of the disease ecology.


1993 ◽  
Vol 70 (1) ◽  
pp. 431-443 ◽  
Author(s):  
E. M. Bowman ◽  
V. J. Brown ◽  
C. Kertzman ◽  
U. Schwarz ◽  
D. L. Robinson

1. A task was used by Posner (1980) to measure shifts of attention that occurred covertly, in the absence of an eye movement or other orienting response. This paradigm was used here to assess the nature of covert attentional orienting in monkeys to develop an animal model for neurophysiological studies. Shifts of attention were measurable in monkeys and were consistent across a variety of experimental conditions. 2. The paradigm required that monkeys fixate and release a bar at the appearance of a target, which was preceded by a cue. Reaction times to targets that followed peripheral cues at the same location (validly cued) were significantly faster than those that followed cues in the opposite visual field (invalidly cued). This difference was defined as the validity effect, which as in humans, is used as the measure of a covert attentional shift. 3. When the proportion of validly to invalidly cued targets was decreased, no change was seen in the validity effect of the monkeys. This is in contrast to humans, for whom the ratio of validly to invalidly cued targets affected the magnitude of the validity effect. When 80% of the targets were preceded by cues at the same location, the validity effect was greatest. The effect was reversed when the proportions were reversed. From this result, it is concluded that cognitive processes can affect covert orienting to peripheral cues in humans, whereas in trained monkeys, performance was automatic. 4. To test whether cognitive influences on attention could be demonstrated in the monkey, an animal was taught to use symbolic, foveal signals to covertly direct attention. The magnitude of this validity effect was greater than that obtained with peripheral cues. 5. The effects of motivational and perceptual processes were tested. Although overall reaction times could be modified, the facilitating effects of the cues persisted. This constancy across motivational and perceptual levels supports the notion that the monkeys were performing the task in an automatic way, under the exogenous control of peripheral cues. 6. Most visual cuing has been tested with visual landmarks at the locations of cues and targets. These monkeys were trained with such landmarks, and when tested without them, the attentional effect of the cues was nearly abolished. These data suggest that local visual features can be important for covert orienting. 7. To determine the spatial extent of the effect of the cue, monkeys and humans were tested with four cue-target distances (0-60 degrees).(ABSTRACT TRUNCATED AT 400 WORDS)


Author(s):  
Elizabeth D. Murphy ◽  
Bernd Lorenz

In research on cognitive issues in automation, spatial visualization ability (SVA) was investigated as a mediator of performance. Prior to performing the experimental task in a simulation environment, 83 undergraduate psychology students completed an on-line version of a test of SVA. The two basic experimental conditions were “monitoring” and “on-call.” In the monitoring condition, participants monitored status messages and responded to system alerts. In the on-call condition, participants performed an unrelated task in between responding to alerts. Dependent measures included decision accuracy. A correlational analysis of SVA scores with decision accuracy found a higher correlation for men than for women. Further analysis indicated that SVA was not a significantly stronger predictor of performance for men than it was for women in the simulated environment. With a larger sample size, however, differential prediction is likely. If confirmed, this finding has implications for the use of SVA in personnel selection. Textual and tabular alternatives to graphical displays may be helpful to low-SVA users.


Author(s):  
Nehad J. Ahmed

Aims: This study aims to review the efficacy of chloroquine and hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) associated pneumonia. Methodology: This review includes searching Google scholar for publications about the use of hydroxychloroquinein the treatment of COVID-19 using the words of (Covid-19) AND hydroxychloroquine. Results: Chloroquine and hydroxychloroquine have proven effective in treating coronavirus in China in vitro, but till now only few clinical trials are available and these trials were conducted on a small sample size of the patients. The efficacy of chloroquine and hydroxychloroquine is mainly due to its effect on angiotensin-converting enzyme II (ACE2). Conclusion: The use of chloroquine and hydroxychloroquine could be very promising but more trials are needed that include larger sample size and more data are required about the comparison between chloroquine and hydroxychloroquine with other antivirals.


Stroke ◽  
2014 ◽  
Vol 45 (suppl_1) ◽  
Author(s):  
Maarten G Lansberg ◽  
Robin Lemmens ◽  
Soren Christensen ◽  
Nishant K Mishra ◽  
Gregory W Albers

Background: Recent trials have shown no benefit of endovascular therapy. This may, in part, be explained by inaccurate estimates of the treatment effect used in the sample size calculations of these trials. A predictive model which includes variables that modify the expected treatment effect might yield more accurate estimates, and could be valuable in the design of future acute stroke trials. Methods: We conducted a literature review to obtain estimates of parameters that are associated with good functional outcome (GFO) following recanalization. We developed a model to estimate the treatment effect in endovascular stroke trials and applied this model to two recently published endovascular stroke trials. Results: We estimated a 40% absolute difference in the proportion of GFO (mRS 0-2 at 90 days) associated with reperfusion in patients with ICA or M1 occlusions who have a substantial ischemic penumbra at baseline. To estimate the effect size in trials, this value was multiplied by: 1) the proportion of patients undergoing endovascular therapy in the active treatment arm; 2) the proportion of patients with occlusions of the ICA or MCA-M1; 3) the proportion of patients with a substantial penumbra and a DWI lesion <50mL; and 4) the absolute difference in the proportion of patients with reperfusion, defined as TICI 2B-3, between the endovascular treatment and control arms. Based on literature review we assumed a reperfusion rate of 20% in the control arms of IMS III and MR Rescue, a 50% prevalence of patients with substantial penumbra and DWI lesions<50 mL in IMS III, and a 75% prevalence in the penumbral arms of MR Rescue. Based on these model inputs, a 2.2% increase in GFO with endovascular therapy was expected in IMS III, which closely matches the observed 2.1% increase. For MR Rescue, the model predicted a 1.5% increase in GFO with endovascular therapy. Considering the small sample size, this equates to 0.5 additional patients with GFO which closely matches the observed result of 3 fewer patients with GFO. Conclusion: A simple model shows promise for estimating the treatment effect of endovascular stroke trials. It may be useful for the design of future trials and could lead to different inclusion criteria or larger sample sizes compared to the recently conducted studies.


Sign in / Sign up

Export Citation Format

Share Document